These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 35106692

  • 1. Uncovering clinical and radiological asymmetry in progressive supranuclear palsy-Richardson's syndrome.
    Picillo M, Tepedino MF, Abate F, Ponticorvo S, Erro R, Cuoco S, Oksuz N, Di Salle G, Di Salle F, Esposito F, Pellecchia MT, Manara R, Barone P.
    Neurol Sci; 2022 Jun; 43(6):3677-3682. PubMed ID: 35106692
    [Abstract] [Full Text] [Related]

  • 2. The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study.
    Seckin ZI, Duffy JR, Strand EA, Clark HM, Utianski RL, Machulda MM, Botha H, Ali F, Thu Pham NT, Lowe VJ, Whitwell JL, Josephs KA.
    Parkinsonism Relat Disord; 2020 Dec; 81():34-40. PubMed ID: 33045651
    [Abstract] [Full Text] [Related]

  • 3. Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants.
    Whitwell JL, Tosakulwong N, Botha H, Ali F, Clark HM, Duffy JR, Utianski RL, Stevens CA, Weigand SD, Schwarz CG, Senjem ML, Jack CR, Lowe VJ, Ahlskog JE, Dickson DW, Josephs KA.
    Neuroimage Clin; 2020 Dec; 25():102152. PubMed ID: 31935638
    [Abstract] [Full Text] [Related]

  • 4. Midbrain atrophy in patients with presymptomatic progressive supranuclear palsy-Richardson's syndrome.
    Ahn JH, Kim M, Kim JS, Youn J, Jang W, Oh E, Lee PH, Koh SB, Ahn TB, Cho JW.
    Parkinsonism Relat Disord; 2019 Sep; 66():80-86. PubMed ID: 31307918
    [Abstract] [Full Text] [Related]

  • 5. Midbrain MRI assessments in progressive supranuclear palsy subtypes.
    Picillo M, Tepedino MF, Abate F, Erro R, Ponticorvo S, Tartaglione S, Volpe G, Frosini D, Cecchi P, Cosottini M, Ceravolo R, Esposito F, Pellecchia MT, Barone P, Manara R.
    J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):98-103. PubMed ID: 31527182
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
    Rizzo G, Martinelli P, Manners D, Scaglione C, Tonon C, Cortelli P, Malucelli E, Capellari S, Testa C, Parchi P, Montagna P, Barbiroli B, Lodi R.
    Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
    [Abstract] [Full Text] [Related]

  • 8. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.
    Williams DR, de Silva R, Paviour DC, Pittman A, Watt HC, Kilford L, Holton JL, Revesz T, Lees AJ.
    Brain; 2005 Jun; 128(Pt 6):1247-58. PubMed ID: 15788542
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsy.
    Seki M, Seppi K, Mueller C, Potrusil T, Goebel G, Reiter E, Nocker M, Steiger R, Wildauer M, Gizewski ER, Wenning GK, Poewe W, Scherfler C.
    Parkinsonism Relat Disord; 2018 Apr; 49():81-87. PubMed ID: 29463454
    [Abstract] [Full Text] [Related]

  • 10. Diffusion tractography of superior cerebellar peduncle and dentatorubrothalamic tracts in two autopsy confirmed progressive supranuclear palsy variants: Richardson syndrome and the speech-language variant.
    Gatto RG, Martin PR, Ali F, Clark HM, Duffy JR, Utianski RL, Botha H, Machulda MM, Dickson DW, Josephs KA, Whitwell JL.
    Neuroimage Clin; 2022 Apr; 35():103030. PubMed ID: 35597031
    [Abstract] [Full Text] [Related]

  • 11. Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism.
    Assogna F, Pellicano C, Cravello L, Savini C, Macchiusi L, Pierantozzi M, Stefani A, Mercuri B, Caltagirone C, Pontieri FE, Spalletta G.
    Brain Behav; 2019 Dec; 9(12):e01448. PubMed ID: 31743601
    [Abstract] [Full Text] [Related]

  • 12. Track density imaging: A reliable method to assess white matter changes in Progressive Supranuclear Palsy with predominant parkinsonism.
    Nigro S, Barbagallo G, Bianco MG, Morelli M, Arabia G, Quattrone A, Gasparini S, Cascini GL, Quattrone A.
    Parkinsonism Relat Disord; 2019 Dec; 69():23-29. PubMed ID: 31665684
    [Abstract] [Full Text] [Related]

  • 13. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.
    Williams DR, Holton JL, Strand C, Pittman A, de Silva R, Lees AJ, Revesz T.
    Brain; 2007 Jun; 130(Pt 6):1566-76. PubMed ID: 17525140
    [Abstract] [Full Text] [Related]

  • 14. The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson's syndrome.
    Sakurai K, Imabayashi E, Tokumaru AM, Hasebe S, Murayama S, Morimoto S, Kanemaru K, Takao M, Shibamoto Y, Matsukawa N.
    Neuroimage Clin; 2015 Jun; 7():605-10. PubMed ID: 26082887
    [Abstract] [Full Text] [Related]

  • 15. Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy.
    Schofield EC, Hodges JR, Macdonald V, Cordato NJ, Kril JJ, Halliday GM.
    Mov Disord; 2011 Feb 01; 26(2):256-63. PubMed ID: 21412832
    [Abstract] [Full Text] [Related]

  • 16. Intracortical diffusion tensor imaging signature of microstructural changes in frontotemporal lobar degeneration.
    Torso M, Ridgway GR, Jenkinson M, Chance S, Frontotemporal Lobar Degeneration Neuroimaging Initiative and the 4-Repeat Tau Neuroimaging Initiative (4RTNI).
    Alzheimers Res Ther; 2021 Oct 22; 13(1):180. PubMed ID: 34686217
    [Abstract] [Full Text] [Related]

  • 17. Temporal Progression Patterns of Brain Atrophy in Corticobasal Syndrome and Progressive Supranuclear Palsy Revealed by Subtype and Stage Inference (SuStaIn).
    Saito Y, Kamagata K, Wijeratne PA, Andica C, Uchida W, Takabayashi K, Fujita S, Akashi T, Wada A, Shimoji K, Hori M, Masutani Y, Alexander DC, Aoki S.
    Front Neurol; 2022 Oct 22; 13():814768. PubMed ID: 35280291
    [Abstract] [Full Text] [Related]

  • 18. Differentiating between common PSP phenotypes using structural MRI: a machine learning study.
    Quattrone A, Sarica A, Buonocore J, Morelli M, Bianco MG, Calomino C, Aracri F, De Maria M, Vescio B, Vaccaro MG, Quattrone A.
    J Neurol; 2023 Nov 22; 270(11):5502-5515. PubMed ID: 37507502
    [Abstract] [Full Text] [Related]

  • 19. Phenotypic Spectrum of Progressive Supranuclear Palsy: Clinical Study and Apolipoprotein E Effect.
    Nasri A, Sghaier I, Neji A, Gharbi A, Abida Y, Mrabet S, Gargouri A, Djebara MB, Kacem I, Gouider R.
    J Mov Disord; 2024 Apr 22; 17(2):158-170. PubMed ID: 38290492
    [Abstract] [Full Text] [Related]

  • 20. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.
    Liscic RM, Srulijes K, Gröger A, Maetzler W, Berg D.
    Acta Neurol Scand; 2013 May 22; 127(5):362-70. PubMed ID: 23406296
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.